Outcomes of primary lymph node staging of intermediate and high risk prostate cancer with 68Ga-PSMA positron emission tomography/computerized tomography compared to histological correlation of pelvic lymph node pathology: can preoperative 68Ga-PSMA positron emission tomography/computerized tomography replace pelvic lymph node dissection for prostate cancer staging?
Effect of adding docetaxel to androgen-deprivation therapy in patients with high-risk prostate cancer with rising prostate-specific antigen levels after primary local therapy: A randomized clinical trial
Head-to-head comparison of TRUS prostate biopsy vs multiparametric prostate resonance imaging with subsequent MR-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: A large prospective multicenter clinical study
Effect on survival of ADT alone compared to ADT combined with concurrent RT to the prostate in patients with primary bone metastatic PCa in a prospective randomised clinical trial: data from the HORRAD trial
Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study
The LANCET Oncology 2018 Nov 20, Volume 20, Issue 1, Pages 100-109
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
Lancet Oncol., Volume 19, Issue 10, September 2018, Pages 1404-1416
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imagingtargeted and Systematic Biopsies